337 related articles for article (PubMed ID: 18545113)
1. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.
Jahr JS; Mackenzie C; Pearce LB; Pitman A; Greenburg AG
J Trauma; 2008 Jun; 64(6):1484-97. PubMed ID: 18545113
[TBL] [Abstract][Full Text] [Related]
2. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
3. Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study.
Jahr JS; Liu H; Albert OK; Gull A; Moallempour M; Lim J; Gosselin R
Am J Ther; 2010; 17(2):140-7. PubMed ID: 19417588
[TBL] [Abstract][Full Text] [Related]
4. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery.
Greenburg AG; Kim HW;
J Am Coll Surg; 2004 Mar; 198(3):373-83; discussion 384-5. PubMed ID: 14992738
[TBL] [Abstract][Full Text] [Related]
5. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
Moore EE; Moore FA; Fabian TC; Bernard AC; Fulda GJ; Hoyt DB; Duane TM; Weireter LJ; Gomez GA; Cipolle MD; Rodman GH; Malangoni MA; Hides GA; Omert LA; Gould SA;
J Am Coll Surg; 2009 Jan; 208(1):1-13. PubMed ID: 19228496
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
7. A safety and efficacy evaluation of hemoglobin-based oxygen carrier HBOC-201 in a randomized, multicenter red blood cell controlled trial in noncardiac surgery patients.
Van Hemelrijck J; Levien LJ; Veeckman L; Pitman A; Zafirelis Z; Standl T
Anesth Analg; 2014 Oct; 119(4):766-776. PubMed ID: 24977631
[TBL] [Abstract][Full Text] [Related]
8. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery.
Hill SE; Gottschalk LI; Grichnik K
J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):695-702. PubMed ID: 12486649
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery.
Wong J; El Beheiry H; Rampersaud YR; Lewis S; Ahn H; De Silva Y; Abrishami A; Baig N; McBroom RJ; Chung F
Anesth Analg; 2008 Nov; 107(5):1479-86. PubMed ID: 18931202
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41).
Dudkiewicz M; Harpaul TA; Proctor KG
Crit Care Med; 2008 Oct; 36(10):2838-48. PubMed ID: 18766094
[TBL] [Abstract][Full Text] [Related]
13. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
[TBL] [Abstract][Full Text] [Related]
14. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion.
Sperry JL; Ochoa JB; Gunn SR; Alarcon LH; Minei JP; Cuschieri J; Rosengart MR; Maier RV; Billiar TR; Peitzman AB; Moore EE;
J Trauma; 2008 Nov; 65(5):986-93. PubMed ID: 19001962
[TBL] [Abstract][Full Text] [Related]
15. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery.
Habler O; Schwenzer K; Zimmer K; Prager M; König U; Oppenrieder K; Pape A; Steinkraus E; Reither A; Buchrot A; Zwissler B
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):467-75. PubMed ID: 15183411
[TBL] [Abstract][Full Text] [Related]
16. Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation.
Massicotte L; Capitanio U; Beaulieu D; Roy JD; Roy A; Karakiewicz PI
Transplantation; 2009 Aug; 88(3):386-91. PubMed ID: 19667942
[TBL] [Abstract][Full Text] [Related]
17. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years?
Duchesne JC; Hunt JP; Wahl G; Marr AB; Wang YZ; Weintraub SE; Wright MJ; McSwain NE
J Trauma; 2008 Aug; 65(2):272-6; discussion 276-8. PubMed ID: 18695461
[TBL] [Abstract][Full Text] [Related]
18. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units.
Inaba K; Teixeira PG; Shulman I; Nelson J; Lee J; Salim A; Brown C; Demetriades D; Rhee P
J Trauma; 2008 Dec; 65(6):1222-6. PubMed ID: 19077605
[TBL] [Abstract][Full Text] [Related]
19. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery.
Bursi F; Barbieri A; Politi L; Di Girolamo A; Malagoli A; Grimaldi T; Rumolo A; Busani S; Girardis M; Jaffe AS; Modena MG
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):311-8. PubMed ID: 19111480
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study.
So-Osman C; Nelissen RG; Eikenboom HC; Brand A
Transfus Med; 2006 Oct; 16(5):321-8. PubMed ID: 16999754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
